Scilex expands Vivasor credit line to $30 million

Scilex Holding Company disclosed in an 8-K filed for a September 25, 2026 event that it amended the terms of a revolving line of credit extended to Vivasor, Inc. The arrangement originated on August 8, 2026, when Scilex entered into a Promissory Note establishing an uncommitted revolving line of credit for Vivasor with a maximum principal amount of up to $20,000,000.¹

Under the amendment signed September 25, 2026, the two companies raised that ceiling to $30,000,000.¹ The company stated that the rest of the note's terms were left unchanged.

The filing notes a leadership tie between the two companies. Dr. Henry Ji, Ph.D., who serves as Scilex's Chief Executive Officer, President and Chairperson, also serves as Chief Executive Officer of Vivasor.¹ Given that overlap, the amendment required approval from both Scilex's Board of Directors and the Board's Audit Committee.¹

The amendment document itself was filed as an exhibit to the 8-K. The exhibit is titled "Amendment to Promissory Note (Revolving Line of Credit), dated September 25, 2026, by and between Vivasor, Inc. and Scilex Holding Company."¹

The 8-K was signed on September 29, 2026 by Stephen Ma, Scilex's Senior Vice President, Chief Operating Officer and Chief Financial Officer, on behalf of the company.